Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9153666 | American Heart Journal | 2005 | 7 Pages |
Abstract
Four weeks of the HIV-1 protease inhibitor indinavir, in the absence of HIV-1 infection, causes vascular dysfunction most likely at the level of endothelial nitric oxide production. The vascular dysfunction may be mediated partially by the concomitant induction of insulin resistance but other mechanisms cannot be ruled out.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sudha S. MD, Michael P. MD, J. Christopher PhD, James E. PhD, MD, Helmut O. MD,